Jagriti Rai (intern journalist), Bhopal: There are 8 vaccines that are currently in different stages of development in the country. But the trial of only one vaccine – covaxin – is being carried out in Madhya Pradesh
The clinical trial for covaxin is being carried at the people’s college of medical sciences and research center (PMCS). The vaccine is being developed by Bharat biotech in Association with the ICMR
At present, the Gandhi medical college (GMC) is waiting for approval from the company and from the ICMR. So, at the moment there is only one vaccine trial that is being carried out in Madhya Pradesh.
Incidentally, GMC which is in category – 2 for the trial, has been deprived of approval because of a shortage of volunteers, while PCSM has claimed that it is getting sufficient volunteers.
Covid 19 vaccine update – covaxin’s phase first trial data shows robust response , says Bharat biotech
The other vaccines that are being developed in India include covishield manufactured by Serum Institute of India (SII) in collaboration with Astra zaneca , a zy covid, a vaccine by Cadila , healthcare that is being jointly developed with the department of biotechnology. Sputnik – v is the fourth vaccine candidate developed by Dr. Reddy’s lab and gamaleya national center in Russia.
NVX – CoV2373 is another vaccine developed by SII and Nova vax. The sixth vaccine is a recombinant protein antigen-based vaccine manufactured by biological E and MIT in the USA
HGCO 19, the seventh one is being manufactured by Genova in Pune in collaboration with HDT, USA. The eighth vaccine is again being developed by Bharat biotech, this time in collaboration with Thomas Jefferson University , USA
If centre doesn’t give free covid 19 vaccine , Maharashtra government will think about it state health minister Rajesh tope.
About Post Author
